Dr Martens has reported that company revenue fell 3.1 per cent to £251 million for the 13 weeks ended 28 December 2025. The brand said it had experienced “mixed” third-quarter trading.
The Northamptonshire-based boot maker said year-to-date revenue stands at £573 million, down 1.8 per cent reported and 0.7 per cent at constant currency.
By region, Dr Martens said performance was “weak” in Europe, Middle East & Africa, and Asia Pacific. EMEA revenue dropped six per cent at constant currency, Asia Pacific fell 2.7 per cent, while Americas grew 2.2 per cent.
“The revenue performance reflects the challenging consumer environment and our continued focus on improving the quality of our revenues by reducing clearance activity and taking a disciplined approach to promotions in direct to consumer thereby increasing the full price mix,” the company said in its statement.
Dr Martens said it continues to focus on “improving the quality of revenue|, with full-price direct-to-consumer sales up two per cent year-to-date.
The brand added that it expects full-year revenue to be broadly flat at constant currency and said that, in line with market expectations, 2026 pre-tax profit is expected to show “significant” year-on-year growth.
In the financial year to March 2025, Dr Martens posted revenue of £787.6 million, reported pre-tax profit of £8.8 million and adjusted pre-tax profit of £34.1 million.
Chief Executive Officer, Ije Nwokorie, said: “This is a year of pivot, as we make the necessary changes to our business to set us up for future sustainable growth.”
